Biomarkers in asthma: state of the art
A Tiotiu - Asthma research and practice, 2018 - Springer
Asthma is a heterogenous disease characterized by multiple phenotypes driven by different
mechanisms. The implementation of precision medicine in the management of asthma …
mechanisms. The implementation of precision medicine in the management of asthma …
Recent developments and highlights in biomarkers in allergic diseases and asthma
I Eguiluz‐Gracia, TR Tay, M Hew, MM Escribese… - Allergy, 2018 - Wiley Online Library
The potential of precision medicine in allergy and asthma has only started to be explored. A
significant clarification in the pathophysiology of rhinitis, chronic rhinosinusitis, asthma, food …
significant clarification in the pathophysiology of rhinitis, chronic rhinosinusitis, asthma, food …
Immunological biomarkers in severe asthma
D Narendra, J Blixt, NA Hanania - Seminars in immunology, 2019 - Elsevier
Severe asthma is heterogeneous in its clinical presentation, underlying pathophysiology,
course and response to therapy. Clinical and physiological assessment of severe asthma is …
course and response to therapy. Clinical and physiological assessment of severe asthma is …
Predictive biomarkers for asthma therapy
SK Medrek, AD Parulekar, NA Hanania - Current allergy and asthma …, 2017 - Springer
Abstract Purpose of Review Asthma is a heterogeneous disease characterized by multiple
phenotypes. Treatment of patients with severe disease can be challenging. Predictive …
phenotypes. Treatment of patients with severe disease can be challenging. Predictive …
Advances in asthma in 2017: Mechanisms, biologics, and genetics
MH Grayson, S Feldman, BT Prince, PJ Patel… - Journal of Allergy and …, 2018 - Elsevier
This review summarizes some of the most significant advances in asthma research over the
past year. We first focus on novel discoveries in the mechanism of asthma development and …
past year. We first focus on novel discoveries in the mechanism of asthma development and …
Mechanisms and biomarkers of airway epithelial cell damage in asthma: a review
Y Yang, M Jia, Y Ou, IM Adcock… - The Clinical Respiratory …, 2021 - Wiley Online Library
Bronchial asthma is a heterogeneous disease with complex pathological mechanisms
representing different phenotypes, including severe asthma. The airway epithelium is a …
representing different phenotypes, including severe asthma. The airway epithelium is a …
[HTML][HTML] Association between blood eosinophils and neutrophils with clinical features in adult-onset asthma
E Flinkman, I Vähätalo, LE Tuomisto… - The Journal of Allergy …, 2023 - Elsevier
Background Asthma is a disease that can be separated into different phenotypes and
endotypes based on the clinical characteristics and the molecular mechanisms of the …
endotypes based on the clinical characteristics and the molecular mechanisms of the …
[HTML][HTML] Biomarkers of bronchial asthma
K Peter, J Fabry, M Lucanska, R Pecova - Physiological research, 2020 - ncbi.nlm.nih.gov
Asthma is a complex disease with a variable course. Efforts to identify biomarkers to predict
asthma severity, the course of disease and response to treatment have not been very …
asthma severity, the course of disease and response to treatment have not been very …
Role of serum periostin in the management of asthma and its comorbidities
H Matsumoto - Respiratory Investigation, 2020 - Elsevier
Type-2 airway inflammation is a major characteristic of asthma. Assessing its degree of
severity is, therefore, essential in asthma management. Periostin, a matricellular protein …
severity is, therefore, essential in asthma management. Periostin, a matricellular protein …
Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma
R Semprini, M Williams, A Semprini, A McDouall… - The Journal of Allergy …, 2018 - Elsevier
Background Type 2 biomarkers that predict both likelihood of future severe exacerbations
and response to mAb therapy in asthma would be useful clinically in identifying patients both …
and response to mAb therapy in asthma would be useful clinically in identifying patients both …